本文从2型糖尿病患者中亚甲减的流行现状,合并亚甲减的可能机制,亚甲减对2型糖尿病病人大血管、微血管病变的影响及2型糖尿病合并亚甲减的治疗四个方面进行综述。 This article from the type 2 diabetic patients in the prevalence of hypothyroidism, the possible mechanism of combined methylenetetrazine reduction, methylene blue in patients with type 2 diabetes mellitus and microvascular lesions and type 2 diabetes mellitus with the treatment of four aspects For review.